News

Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. Although the ...
Alcon has tested Unity VCS during investigational advisory wet lab sessions with more than 200 highly experienced surgeons from 30+ countries. Commercial launch of Unity VCS is expected in early 2026.
SINGAPORE – Eye-care device firm Alcon Manufacturing and Logistics announced the opening of its expanded manufacturing and logistics facility on June 27. The facility, located in Tuas, will ...
Michelle Dixon, VP of Manufacturing & Technical Operations Management for Vision Care, Alcon, said the expansion will also create high-value jobs across production, quality control, and distribution.
‘Blade Runner 2049’ Producer Alcon Wins Bid For Village Roadshow’s Film Library The 108 films generate $50 million annually. The purchase positions Alcon as the owner of one of the largest ...
Alcon Media Group LLC has won its $417.5 million bid to acquire Village Roadshow Entertainment Group’s library of 108 feature film titles.
Alcon Media Group has won its $417.5 million bid to acquire the film catalog of Village Roadshow, which declared bankruptcy this past March. Alcon, which already has films like “Blade Runner ...
Alcon, a global leader in eye care introduces PRECISION1, its next-generation daily disposable contact lenses, designed to deliver up to 16 hours of comfort. PRECISION1– India’s 1st SMARTSURFACE lens ...
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.
Alcon (NYSE:ALC) shares fell 9% in premarket trading on Wednesday, after the Swiss-American pharmaceutical and medical device company missed estimates for quarterly earnings.
Alcon Inc.'s strong growth, strategic acquisitions, and market leadership highlight its long-term potential. Read more on ALC stock prospects.